Related Experiment Videos
Hypersensitivity reaction to intravitreal clindamycin therapy
Peter Kim1, Nancy Younan, Minas T Coroneo
1Department of Ophthalmology, Prince of Wales Hospital, University of New South Wales, Sydney, New South Wales, Australia.
Clinical & Experimental Ophthalmology
|March 12, 2002
Summary
Intraocular toxoplasmosis treatment with intravitreal clindamycin can cause hypersensitivity reactions, such as a generalized rash. This is the first reported case of such a reaction to an intravitreal antibiotic.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Intraocular toxoplasmosis is an infection of the eye caused by the parasite *Toxoplasma gondii*.
- Treatment often involves antimicrobial agents, with intravitreal injections sometimes used for severe or recurrent cases.
- Clindamycin is a common antibiotic used to treat toxoplasmosis.
Observation:
- A patient with recurrent intraocular toxoplasmosis received intravitreal clindamycin.
- Following administration, the patient developed a widespread erythematous rash.
- This rash was identified as a hypersensitivity reaction.
Findings:
- The patient experienced a generalized erythematous rash after intravitreal clindamycin injection.
- This event represents a hypersensitivity reaction to the administered antibiotic.
- This is the first documented instance of such a reaction to an intravitreal antibiotic.
Implications:
- Clinicians should be aware of the potential for hypersensitivity reactions to intravitreal antibiotics.
- This case highlights the importance of monitoring patients for adverse reactions after intravitreal drug administration.
- Further research may be needed to understand the incidence and mechanisms of hypersensitivity to intravitreal antibiotics.